The U.S. Food and Drug Administration (FDA) has officially approved Orca Bio’s groundbreaking cell therapy, Tregzi (also known as Orca-T). It is …
Anthropic has officially announced the launch of Claude Science, an advanced platform designed to accelerate global health innovations. Claude Science by Anthropic …
Ipsen, the biopharmaceutical company, recently announced a definitive merger agreement to acquire Kartos Therapeutics. Under this Ipsen Kartos Therapeutics Acquisition, the French …
The U.S. Food and Drug Administration (FDA) has launched a groundbreaking initiative to accelerate regulatory reviews for new domestic drug production plants. …
The intense, 11-day historic heatwave in France has finally begun to ease as cooler air moves across the country. However, the human …
The French Health Ministry announced that the humanitarian doctor who recently returned from a mission in the Democratic Republic of the Congo …
In a major move, Passage Bio and Remix Therapeutics have officially announced a definitive agreement to combine their businesses. The Passage Bio …
An urgent fruit pack recall in UK supermarkets has been launched following a major food safety alert. Several pre-packaged fruit pots and …
One of the biotechnology industry’s longtime pioneers in gene therapy, Sangamo Therapeutics has filed for Chapter 11 bankruptcy protection. With this, the …
In a suspected case, the deadly bird flu strain in Australia has been detected for the first time, which could end the …
During the latest Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, the FDA panel recommended Moderna’s flu shot, mRNA-1010, for older …
The U.S. Food and Drug Administration (FDA) has approved the first generic version of the Pharmaceutical company Roche’s flu drug Xofluza (baloxavir marboxil). …
The U.S. Food and Drug Administration (FDA) has officially approved Orca Bio’s groundbreaking cell therapy, Tregzi (also known as Orca-T).
Anthropic has officially announced the launch of Claude Science, an advanced platform designed to accelerate global health innovations. Claude Science
Ipsen, the biopharmaceutical company, recently announced a definitive merger agreement to acquire Kartos Therapeutics. Under this Ipsen Kartos Therapeutics Acquisition,
The U.S. Food and Drug Administration (FDA) has launched a groundbreaking initiative to accelerate regulatory reviews for new domestic drug
The intense, 11-day historic heatwave in France has finally begun to ease as cooler air moves across the country. However,
The French Health Ministry announced that the humanitarian doctor who recently returned from a mission in the Democratic Republic of
In a major move, Passage Bio and Remix Therapeutics have officially announced a definitive agreement to combine their businesses. The
An urgent fruit pack recall in UK supermarkets has been launched following a major food safety alert. Several pre-packaged fruit
One of the biotechnology industry’s longtime pioneers in gene therapy, Sangamo Therapeutics has filed for Chapter 11 bankruptcy protection. With
In a suspected case, the deadly bird flu strain in Australia has been detected for the first time, which could
During the latest Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, the FDA panel recommended Moderna’s flu shot, mRNA-1010,
The U.S. Food and Drug Administration (FDA) has approved the first generic version of the Pharmaceutical company Roche’s flu drug Xofluza
